A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

CoTherix Inc

About CoTherix:

CoTherix, Inc. is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. On December 29, 2004, the U.S. Food and Drug Administration approved CoTherix’s lead product, Ventavis™ (iloprost) Inhalation Solution, for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.


Product Pipeline Data for CoTherix


NIH Data for Trials CoTherix Iloprost --Pulmonary Arterial Hypertension PAH Pulmonary Hypertension


More on CoTherix :

Home Page

Key Statistics for CoTherix

Basic Chart for CoTherix

Analyst Opinion

Analysts Estimates

CoTherix News

Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.